Maca vs Cannabis – modulating the endocannabinoid system

Since the discovery of the endocannabinoid (CB1) receptor in 1993 there has been huge interest in the use of plant-based cannabinoids for modulating the body’s response to stress.

New research has demonstrated that the effectiveness of monotreatment with CB1 agonists like CBD and THC may be limited and the future may lie in a combination therapy involving a novel class of cannabinoid modulating FAAH inhibitors.

Come and learn all about the endocannabinoid system and how it can combat chronic stress.